Ashwani Gujral of ashwanigujral.com is of the view that one can buy Hexaware Technologies, HDIL, DLF and Zee Entertainment.
Ashwani Gujral of ashwanigujral.com is of the view that one can buy Hindalco Industries, JSW Energy and BEML and hold Jaiprakash Associates.
In an interview to CNBC-TV18, Sanjiv Bhasin of IIFL shared his reading and outlook on the market.
Rakesh Bansal of RK Global advises buying HFCL with a target of Rs 21.
The acquisition will give UltraTech access to the attractive central India market, where it currently has limited presence, says Morgan Stanley.
Krish Subramanyam of Altamount Capital is of the view that one can buy Ashok Leyland June futures and sell 102.5 Call.
Rakesh Bansal of RK Global is of the view that one may buy CESC with a target of Rs 618.
Krish Subramanyam of Altamount Capital recommends buying NCC and Jaiprakash Associates.
Sharmila Joshi of sharmilajoshi.com suggests exiting Jaiprakash Associates.
SP Tulsian of sptulsian.com is of the view that one may see profit booking in Geometric.
In a major relief from its debt burden, Jaiprakash Associates (JPA) finally inked the much-awaited deal to sell its cement assets to Aditya Birla Group firm UltraTech Cement on Thursday for Rs 15,900 crore.
Vijay Chopra of enochventures.com advises exiting Jaiprakash Associates.
Ashu Madan of Religare Securities suggests exiting Jaiprakash Associates.
Rakesh Bansal of RK Global recommends holding Jaiprakash Associates.
Vishal Malkan of malkansview.com advises buying Jubilant Life Sciences with a target of Rs 470.
Nooresh Merani of Analyse India is of the view that one may hold Jaiprakash Associates.
Rakesh Bansal of RK Global recommends buying Jindal Saw with a target of Rs 78 and Bharat Forge with a target of Rs 990.
Hemen Kapadia of KRChoksey Securities is of the view that one may sell Jaiprakash Associates and pick TV18 Broadcast.
Ashish Kyal of wavesstrategy.com recommends buying Amara Raja Batteries and advises selling Steel Authority of India and Jaiprakash Associates.
Pharma Analyst Surajit Pal is not very keen on holding pharma biggies, given the newsflows that are associated with them. Lupin first quarter earnings have been disappointing and Pal believes the pain is going to continue for two-three months. Another big-ticket stock Sun Pharma too have seen a steep fall after it issued profit warning.
Gaurang Shah of Geojit BNP Paribas Financial Services suggests selling Jaiprakash Associates on rally.
Vishal Malkan of malkansview.com advises exiting Jaiprakash Associates and prefers pharma stocks.
CNBC-TV18‘s Varinder Bansal gives a check on the best & worst performing stocks in this last one year of Modi government.
VK Sharma of HDFC Securities is of the view that one can buy Jaiprakash Associates 17.50 Put.
Manas Jaiswal of manasjaiswal.com advises selling Tata Motors and Jaiprakash Associates.